163 related articles for article (PubMed ID: 21072979)
21. [Drug resistance in antiretroviral therapy of HIV infection].
Oette M; Häussinger D
Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
[TBL] [Abstract][Full Text] [Related]
22. HIV eradication theory meets reality.
TreatmentUpdate; 1999 May; 11(3):3. PubMed ID: 11366779
[TBL] [Abstract][Full Text] [Related]
23. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.
Sosnik A; Chiappetta DA; Carcaboso AM
J Control Release; 2009 Aug; 138(1):2-15. PubMed ID: 19445981
[TBL] [Abstract][Full Text] [Related]
24. The design of drugs for HIV and HCV.
De Clercq E
Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
[TBL] [Abstract][Full Text] [Related]
25. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F
Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760
[TBL] [Abstract][Full Text] [Related]
26. Practical issues regarding the use of antiretroviral therapy for HIV infection.
Deeks SG
West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
[TBL] [Abstract][Full Text] [Related]
27. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
28. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
29. The challenge of finding a cure for HIV infection.
Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ
Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012
[TBL] [Abstract][Full Text] [Related]
30. Advances in HIV/AIDS therapy.
Johnson SC; Gerber JG
Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
[TBL] [Abstract][Full Text] [Related]
31. Maraviroc: new drug. Multiple antiretroviral treatment failure: too soon to reach conclusions.
Prescrire Int; 2008 Jun; 17(95):98-101. PubMed ID: 18623908
[TBL] [Abstract][Full Text] [Related]
32. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
[TBL] [Abstract][Full Text] [Related]
33. Antiretroviral drug development: the challenge of cost and access.
Dunne M
AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
[TBL] [Abstract][Full Text] [Related]
34. Determinants of virological response to antiretroviral therapy: implications for long-term strategies.
Deeks SG
Clin Infect Dis; 2000 Jun; 30 Suppl 2():S177-84. PubMed ID: 10860903
[TBL] [Abstract][Full Text] [Related]
35. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
36. Worldwide transmission of drug-resistant HIV.
Wensing AM; Boucher CA
AIDS Rev; 2003; 5(3):140-55. PubMed ID: 14598563
[TBL] [Abstract][Full Text] [Related]
37. [Antiretroviral drugs 1998/1999].
Rieger A
Wien Med Wochenschr; 1998; 148(23-24):567-76. PubMed ID: 10189688
[TBL] [Abstract][Full Text] [Related]
38. Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy.
Nicastri E; Sarmati L; d'Ettorre G; Palmisano L; Parisi SG; Uccella I; Rianda A; Concia E; Vullo V; Vella S; Andreoni M
J Med Virol; 2003 Jan; 69(1):1-6. PubMed ID: 12436471
[TBL] [Abstract][Full Text] [Related]
39. HIV reservoirs: the new frontier.
Iglesias-Ussel MD; Romerio F
AIDS Rev; 2011; 13(1):13-29. PubMed ID: 21412386
[TBL] [Abstract][Full Text] [Related]
40. Potential new therapies for the treatment of HIV-1 infection.
Condra JH; Miller MD; Hazuda DJ; Emini EA
Annu Rev Med; 2002; 53():541-55. PubMed ID: 11818489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
